Cargando…
Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores)
BACKGROUND: The Oxford classification of IgA nephropathy (IgAN) defines histologic criteria (MEST-C) that provide prognostic information based on the kidney biopsy. There are few data on the predictive impact of this classification in randomized clinical trial settings. METHODS: We performed an expl...
Autores principales: | Schimpf, Judith Isabel, Klein, Till, Fitzner, Christina, Eitner, Frank, Porubsky, Stefan, Hilgers, Ralf-Dieter, Floege, Jürgen, Groene, Hermann-Josef, Rauen, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245781/ https://www.ncbi.nlm.nih.gov/pubmed/30453889 http://dx.doi.org/10.1186/s12882-018-1128-6 |
Ejemplares similares
-
Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy
por: Lennartz, David Paul, et al.
Publicado: (2020) -
IgAN Genetic Risk Score in the Clinical Setting
por: Schena, Francesco Paolo, et al.
Publicado: (2020) -
New directions in the pathogenesis of primary erythrocytosis in IgAN
por: Schena, Francesco Paolo, et al.
Publicado: (2022) -
Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)
por: De Angelis, Maria, et al.
Publicado: (2014) -
Proteomic signature of tubulointerstitial tissue predicts prognosis in IgAN
por: Paunas, Flavia Teodora Ioana, et al.
Publicado: (2022)